Therapeutic Delivery – Products

Product News
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration With Thermo Fisher Scientific for Long-Acting Oral Therapies
Lyndra Therapeutics, a clinical-stage biopharmaceutical company, announced a strategic collaboration with Thermo Fisher Scientific Inc.

Product News
ABITEC Unveils Comprehensive Custom Lipid Synthesis Capabilities for LNP Therapeutics
LNP developers now have access to bench-to-patient lipid synthesis support from a single partner.

Product News
New Scientific Advisory Board Members
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce three new members to its Scientific Advisory Board (SAB).

Product News
Thermo Fisher Scientific Introduces Invitrogen™ Vivofectamine™ Delivery Solutions To Help Advance Life Science Research and Genetic Medicines
Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

Product News
Aptamer Extends Agreement With Genetic Medicines Customer
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders, is pleased to announce that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.

Product News
Evotec and Bristol Myers Squibb Expand Proteomics Partnership
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced progress within the Company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline.

Product News
Lonza Extends Collaboration With Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza, announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs.

Product News
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
Thermo Fisher Scientific Inc., will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024, Oct. 8-10, in Milan, Italy.

Product
Advertisement
Comprehensive Solutions for Lipid Nanoparticle Research
The trusted lipid experts at Cayman Chemical provide industry-leading solutions for every stage of LNP R&D, from high-purity lipids and research-ready LNPs to LNP formulation, screening, and CGMP lipid manufacturing services.

Product News
BD Showcases Latest Drug Delivery Innovations at CPhI Milan 2024
BD (Becton, Dickinson and Company), will highlight its newest innovations in drug delivery systems at CPhI Milan 2024 on October 8th and 9th in Milan, Italy.
Advertisement